F2 and congenital afibrinogenemia: Secondary fibrinolysis was observed in a further 40% of patients belonging to the same group, marked by significant increase of the FDPs and at least two other defective clotting factors (afibrinogenemia, thrombocytopenia or prolonged prothrombin time).